FDA Rejects New Drug Sparlon After Link To SJS
Posted by M. Brandon Smith
August 10, 2006 4:59 PM
August 10, 2006 4:59 PM
The Legal Examiner Atlanta is brought to you by Childers, Schlueter & Smith
Childers, Schlueter & Smith
(800) 641-0098www.cssfirm.com
1932 North Druid Hills Road
Suite 100
Atlanta, Georgia 30319
[Show Map]
Personal Injury Lawyers Serving:
Atlanta, Macon, Marietta, Norcross, Roswell, Sandy Springs, Smyrna, Buckhead, College Park, Covington, Conyers, Decatur, Duluth, Forest Park just to name a few. Also serving communities throughout the entire State of Georgia and across the nation for dangerous drugs and defective medical products cases.
Archives
Categories
- Automobile Accidents
- Defective & Dangerous Products
- FDA & Prescription Drugs
- Head & Brain Injuries
- Mass Transit (Airline, Cruise Ship, Train, Bus)
- Medical Devices & Implants
- Medical Malpractice
- Miscellaneous
- Motorcycle Accidents
- Nursing Home & Elder Abuse
- Property Owner's Liability (Slip & Fall)
- Spinal Cord Injuries
- Toxic Substances
- Tractor-Trailer Accidents
- Uncategorized
- Workplace Injuries
- Wrongful Death
Subscribe to The Legal Examiner
Keep up with the latest updates using your favorite RSS reader

The Food and Drug Administration recently rejected approval of Cephalon Inc.’s newest drug Sparlon, an attention deficit/hyperactivity disorder drug, after it was found to trigger Stevens-Johnson Syndrome (SJS), a serve allergic reaction that often times is fatal. The debilitating drug induced reaction kills thousands of consumers each year and was determined to be too great a risk for the public at large. Finally, the FDA is taking a firm stand on new drugs related to and triggering SJS. Now if they would help facilitate the removal of other dangerous drugs connected to SJS already on the market we all would be a lot safer when it comes to dealing with this tragic allergic reaction.